Physician profile
Ryan S Hoffman
NPI 1861696320
$5,942.95
in general payments reported to CMS, 2019-2025
28 companies · $1,374 in 2025
The $1,374 reported for 2025 was more than what 77% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,833 · 2020: $126 · 2021: $273 · 2022: $319 · 2023: $338 · 2024: $679 · 2025: $1,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,925 · Travel and Lodging: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,925.40 |
| Travel and Lodging | $465.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,820.56 | 2019-2022 | |
| Supreme Orthopedic Systems, LLC | $465.73 | 2024 | |
| Galderma Laboratories, L.P. | $412.56 | 2019-2025 | Dysport |
| Abbvie INC. | $383.90 | 2023-2025 | |
| Polynovo North America LLC | $338.97 | 2025 | Novosorb Btm |
| Mentor Worldwide LLC | $253.23 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Integra Lifesciences Corporation | $218.11 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Smith+Nephew, INC. | $171.15 | 2019-2023 | Pico 7, Collagenase Santyl |
| Baxter Healthcare | $145.08 | 2019-2025 | Tisseel |
| Medtronic, INC. | $95.86 | 2023-2025 | Transorb, Intellis Adaptivestim, Signia |
| Davol INC. | $76.05 | 2023-2025 | Arista Ah Flexitip, Phasix Mesh |
| Sientra, INC. | $71.68 | 2019 | |
| Aroa Biosurgery Incorporated | $58.13 | 2019-2024 | |
| Lumenis, INC | $51.52 | 2021 | |
| Solventum Corporation | $45.88 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $41.57 | 2021-2022 | |
| Stryker Corporation | $41.23 | 2021 | |
| Tela Bio, INC. | $41.10 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Coopersurgical, INC. | $33.04 | 2019-2020 | |
| Rti Surgical, INC | $32.75 | 2025 | |
| Misonix INC | $23.51 | 2020 | |
| Medline Industries LP | $22.34 | 2019 | |
| Checkpoint Surgical, INC | $20.09 | 2023 | Checkpoint Stimulators |
| Motiva USA, LLC | $18.78 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $18.08 | 2025 | Caldolor |
| Mimedx Group, INC. | $16.81 | 2025 | |
| Kerecis Limited | $13.31 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Mission Pharmacal Company | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.